Abstract
In a recent study published in Cell Stem Cell, Hu etal. (2019) used human adipose stem cell-derived adipocytes to demonstrate that genetic variation predicts anti-diabetic response to thiazolidinediones (TZDs) by modulating PPARγ binding.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have